BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 1, 2013, Pages 33-38

  Kraszewska, Monika D ^a   Dawidowska, Małgorzata ^a   Kosmalska, Maria ^a   Sedek, Łukasz ^b   Grzeszczak, Władysław ^b   Kowalczyk, Jerzy R ^c   Szczepański, Tomasz ^b   Witt, Michał ^a,d,e   Lejman, Monika ^c   Jacek Wachowiak, Katarzyna Derwich ^f   Trelinska, Joanna ^g   Mlynarski, Ojciech ^g   Sobol, grazyna ^b   Maryna Krawczuk Rybak, Matarzyna Muszynska Roslan ^h   Badowska, Wanda ⁱ   Anna Balcerska, Maciej Niedzwiecki ^j   Wieczorek, Maria ^k   Tomasz Urasinski, Tomasz Ociepa ^l   Tomaszewska, Renata ^b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

ⁱ Pediatric Hospital   (Poland)

^j MEDICAL UNIVERSITY OF GDANSK   (Poland)

^k Pediatric and Oncological Hospital in Chorzów   (Poland)

^l POMERANIAN MEDICAL UNIVERSITY   (Poland)

more..

Author keywords

BCL11B; FBXW7; FLT3; NOTCH1; Pediatric T ALL

Indexed keywords

BCL11B PROTEIN; CD135 ANTIGEN; FBXW7 PROTEIN; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BCL11B GENE; FBXW7 GENE; FLT3 GENE; GENE; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MUTATION RATE; NOTCH1 GENE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA;

EID: 84869863921     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.09.001     Document Type: Article

References (28)

1. Kraszewska M.D., Dawidowska M., Szczepański T., Witt M. T-cell acute lymphoblastic leukemia: recent findings on molecular biology. Br. J. Haematol. 2012, 156:303-315.
2. Breit S., Stanulla M., Flohr T., Schrappe M., Ludwig W.D., Tolle G., Happich M., Muckenthaler M.U., Kulozik A.E. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 2006, 108:1151-1157.
3. Clappier E., Collette S., Grardel N., Girard S., Suarez L., Brunie G., Kaltenbach S., Yakouben K., Mazingue F., Robert A., Boutard P., Plantaz D., Rohrlich P., van Vlierberghe P., Preudhomme C., Otten J., Speleman F., Dastugue N., Suciu S., Benoit Y., Bertrand Y., Cave H. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 2010, 24:2023-2031.
4. Zuurbier L., Homminga I., Calvert V., te Winkel M.L., Buijs-Gladdines J.G., Kooi C., Smits W.K., Sonneveld E., Veerman A.J., Kamps W.A., Horstmann M., Petricoin E.F., Pieters R., Meijerink J.P. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010, 24:2014-2022.
5. O'Neil J., Grim J., Strack P., Rao S., Tibbitts D., Winter C., Hardwick J., Welcker M., Meijerink J.P., Pieters R., Draetta G., Sears R., Clurman B.E., Look A.T. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 2007, 204:1813-1824.
6. Kox C., Zimmermann M., Stanulla M., Leible S., Schrappe M., Ludwig W.D., Koehler R., Tolle G., Bandapalli O.R., Breit S., Muckenthaler M.U., Kulozik A.E. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia 2010, 24:2005-2013.
7. van Grotel M., Meijerink J.P., Beverloo H.B., Langerak A.W., Buys-Gladdines J.G., Schneider P., Poulsen T.S., den Boer M.L., Horstmann M., Kamps W.A., Veerman A.J., van Wering E.R., van Noesel M.M., Pieters R. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 2006, 91:1212-1221.
8. Larson Gedman A., Chen Q., Kugel Desmoulin S., Ge Y., LaFiura K., Haska C.L., Cherian C., Devidas M., Linda S.B., Taub J.W., Matherly L.H. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009, 23:1417-1425.
9. Weng A.P., Ferrando A.A., Lee W., Morris J.P., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (New York, N.Y.) 2004, 306:269-271.
10. Asnafi V., Buzyn A., Le Noir S., Baleydier F., Simon A., Beldjord K., Reman O., Witz F., Fagot T., Tavernier E., Turlure P., Leguay T., Huguet F., Vernant J.P., Daniel F., Bene M.C., Ifrah N., Thomas X., Dombret H., Macintyre E. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 2009, 113:3918-3924.
11. Thompson B.J., Buonamici S., Sulis M.L., Palomero T., Vilimas T., Basso G., Ferrando A., Aifantis I. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 2007, 204:1825-1835.
12. Paietta E., Ferrando A.A., Neuberg D., Bennett J.M., Racevskis J., Lazarus H., Dewald G., Rowe J.M., Wiernik P.H., Tallman M.S., Look A.T. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood 2004, 104:558-560.
13. Van Vlierberghe P., Meijerink J.P., Stam R.W., van der Smissen W., van Wering E.R., Beverloo H.B., Pieters R. Activating FLT3 mutations in CD4+/CD8-pediatric T-cell acute lymphoblastic leukemias. Blood 2005, 106:4414-4415.
14. Nakao M., Janssen J.W., Erz D., Seriu T., Bartram C.R. Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease. Leukemia 2000, 14:522-524.
15. Mansur M.B., Emerenciano M., Splendore A., Brewer L., Hassan R., Pombo-de-Oliveira M.S. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements. Leuk. Res. 2010, 34:483-486.
16. Libura M., Asnafi V., Tu A., Delabesse E., Tigaud I., Cymbalista F., Bennaceur-Griscelli A., Villarese P., Solbu G., Hagemeijer A., Beldjord K., Hermine O., Macintyre E. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood 2003, 102:2198-2204.
17. Dik W.A., Pike-Overzet K., Weerkamp F., de Ridder D., de Haas E.F., Baert M.R., van der Spek P., Koster E.E., Reinders M.J., van Dongen J.J., Langerak A.W., Staal F.J. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J. Exp. Med. 2005, 201:1715-1723.
18. Przybylski G.K., Dik W.A., Wanzeck J., Grabarczyk P., Majunke S., Martin-Subero J.I., Siebert R., Dolken G., Ludwig W.D., Verhaaf B., van Dongen J.J., Schmidt C.A., Langerak A.W. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005, 19:201-208.
19. Bernard O.A., Busson-LeConiat M., Ballerini P., Mauchauffe M., Della Valle V., Monni R., Nguyen Khac F., Mercher T., Penard-Lacronique V., Pasturaud P., Gressin L., Heilig R., Daniel M.T., Lessard M., Berger R. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001, 15:1495-1504.
20. De Keersmaecker K., Real P.J., Gatta G.D., Palomero T., Sulis M.L., Tosello V., Van Vlierberghe P., Barnes K., Castillo M., Sole X., Hadler M., Lenz J., Aplan P.D., Kelliher M., Kee B.L., Pandolfi P.P., Kappes D., Gounari F., Petrie H., Van der Meulen J., Speleman F., Paietta E., Racevskis J., Wiernik P.H., Rowe J.M., Soulier J., Avran D., Cave H., Dastugue N., Raimondi S., Meijerink J.P., Cordon-Cardo C., Califano A., Ferrando A.A. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat. Med. 2010, 16:1321-1327.
21. Gutierrez A., Kentsis A., Sanda T., Holmfeldt L., Chen S.C., Zhang J., Protopopov A., Chin L., Dahlberg S.E., Neuberg D.S., Silverman L.B., Winter S.S., Hunger S.P., Sallan S.E., Zha S., Alt F.W., Downing J.R., Mullighan C.G., Look A.T. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 2011, 118:4169-4173.
22. Kraszewska M.D., Dawidowska M., Kosmalska M., Sedek L., Grzeszczak W., Szczepanski T., Witt M. Immunoglobulin/T-cell receptor gene rearrangements in the diagnostic paradigm of pediatric T-cell acute lymphoblastic leukemia patients. Leuk. Lymphoma 2012, 7:1425-1428.
23. Pieters R., Schrappe M., De Lorenzo P., Hann I., De Rossi G., Felice M., Hovi L., LeBlanc T., Szczepanski T., Ferster A., Janka G., Rubnitz J., Silverman L., Stary J., Campbell M., Li C.K., Mann G., Suppiah R., Biondi A., Vora A., Valsecchi M.G. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007, 370:240-250.
24. Nakao M., Yokota S., Iwai T., Kaneko H., Horiike S., Kashima K., Sonoda Y., Fujimoto T., Misawa S. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996, 10:1911-1918.
25. Iwai T., Yokota S., Nakao M., Okamoto T., Taniwaki M., Onodera N., Watanabe A., Kikuta A., Tanaka A., Asami K., Sekine I., Mugishima H., Nishimura Y., Koizumi S., Horikoshi Y., Mimaya J., Ohta S., Nishikawa K., Iwai A., Shimokawa T., Nakayama M., Kawakami K., Gushiken T., Hyakuna N., Fujimoto T., et al. Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia 1999, 13:38-43.
26. Park M.J., Taki T., Oda M., Watanabe T., Yumura-Yagi K., Kobayashi R., Suzuki N., Hara J., Horibe K., Hayashi Y. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br. J. Haematol. 2009, 145:198-206.
27. Kraszewska M.D., Dawidowska M., Larmonie N.S., Kosmalska M., Sedek L., Szczepaniak M., Grzeszczak W., Langerak A.W., Szczepanski T., Witt M. DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL. Leukemia 2012, 26:367-371.
28. Huang X., Shen Q., Chen S., Yang L., Weng J., Du X., Grabarczyk P., Przybylski G.K., Schmidt C.A., Li Y. Gene expression profiles in BCL11B-siRNA treated malignant T cells. J. Hematol. Oncol. 2011, 4:23.